📌 Key Takeaways
- Topic: Silica as a Toothpaste Abrasive: How It Cleans and How RDA Is Controlled
- Keywords: quartz crucible sand
- Published: 2026-11-20 00:54:28
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is the Molar Mass of Silicon Dioxide (SiO₂)? Calculation Explained
- Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
- Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nat. Mater. 12, 991-1003 (2013). Piece CAS PubMed Google Scholar
- Silicon Dioxide CAS 7631-86-9: Identification, Properties and Regulatory Information
- Li, Z. et al. Synergistic lysozyme‐photodynamic therapy against resistant bacteria based on an intelligent upconversion nanoplatform. Angew. Chem. Int. Ed. 60, 19201-19206 (2021). Piece CAS Google Scholar
- Silica Sol Manufacturer: Product Types, Quality Control and How to Choose
- High Purity Quartz Market 2026: Supply, Demand and Price Outlook
- Cordeiro, R. A., Mendonça, P. V., Coelho, J. & Faneca, H. Engineering silica-polymer hybrid nanosystems for dual drug and gene delivery. Biomater. Adv. 135, 212742 (2022). Post CAS PubMed Google Scholar
How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes
What is silica (SiO₂)?
silica polishing agent
What is the difference between fumed silica and precipitated silica?
silicon oxide
What drives silica raw material prices?
quartz Secondly, it is needed to construct simple but efficient MSNs-based nanoplatforms. The abundant traits of MSNs have led to their vast exploitation as multifunctional nanocarriers, and this may be accompanied by the introduction of two or more elements into MSNs. Although these multifunctional nanoplatforms have proven to be really effective in numerous papers, the complexity of these platforms does not appear to be friendly to the scale-up preparation and clinical translation. On the one hand, it is well known that the laboratory-level synthesis methods of MSN are very different from those used for industrial scale-up production required for clinical screening and use. The reproducibility and batch stability of nanoformulations are always an important component to consider in industrial scale-up production, and in this process, simplifying the production steps is the key to promote the industrial scale-up production. Nonetheless, the complex MSNs-based nanoplatforms call for higher nanoformulation preparation technologies and more stringent storage methods, which often call for more time, effort, and economic investments. On the other hand, the multiple components may introduce more unsafe factors, it appears to be an enormous challenge at this stage to systematically reveal the toxicity mechanisms of these different components when we still do not entirely understand the toxicity mechanisms of MSNs. Hence, it is advocated to slim down the MSNs-based platform as much as possible while meeting the clinical requirements.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.